 |
JOURNAL TOOLS |
| Opzioni di pubblicazione |
| eTOC |
| Per abbonarsi |
| Sottometti un articolo |
| Segnala alla tua biblioteca |
ARTICLE TOOLS |
| Publication history |
| Estratti |
| Permessi |
| Per citare questo articolo |
| Share |
I TUOI DATI
I TUOI ORDINI
CESTINO ACQUISTI
N. prodotti: 0
Totale ordine: € 0,00
COME ORDINARE
I TUOI ABBONAMENTI
I TUOI ARTICOLI
I TUOI EBOOK
COUPON
ACCESSIBILITÀ
LETTERS TO THE EDITOR
Panminerva Medica 2018 September;60(3):136-7
DOI: 10.23736/S0031-0808.18.03446-8
Copyright © 2018 EDIZIONI MINERVA MEDICA
lingua: Inglese
Why is there an emerging need to look for a suitable drug delivery platform in targeting and regulating microbiota?
Kamal DUA 1, 2, 3 ✉, Gaurav GUPTA 4, Rajendra AWASTHI 5, Dinesh K. CHELLAPPAN 6
1 Section of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, Australia; 2 School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, Australia; 3 Priority Research Center for Healthy Lungs, Hunter Medical Research Institute, Newcastle, Australia; 4 Jaipur National University, School of Pharmaceutical Sciences, Jagatpura, Jaipur, India; 5 NKBR College of Pharmacy and Research Center, Meerut, India; 6 Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia